Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.

Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.
复制标题

DOI:
10.1038/onc.2009.434
复制
发表时间:
2010-03-11
期刊:
影响因子:
8
通讯作者:
Alarid, E. T.
Alarid, E. T.
中科院分区:
医学1区
文献类型:
--
作者:
Powers, G. L.;Ellison-Zelski, S. J.;Casa, A. J.;Lee, A. V.;Alarid, E. T.

文献摘要

参考文献

被引文献

相似文献

Estrogen receptor-alpha (ERα) is a major therapeutic target of hormonal therapies in breast cancer and its expression in tumors is predictive of clinical response. Protein levels of ERα are tightly controlled by the 26S proteasome, yet how the clinical proteasome inhibitor, bortezomib, impacts ERα regulation has not been studied. Bortezomib selectively inhibits the chymotrypsin-like activity of the proteasome. Unlike other laboratory proteasome inhibitors, bortezomib failed to stabilize ERα protein at a dose exceeding 90% inhibition of the chymotrypsin-like activity. Unexpectedly, however, chronic bortezomib exposure caused a reduction of ERα levels in multiple ER+ breast cancer cell lines. This response can be explained by the fact that bortezomib induced a dramatic decrease in ERα mRNA due to direct transcriptional inhibition and loss of RNA polymerase II recruitment on the ERα gene promoter. Bortezomib treatment resulted in promoter-specific changes in estrogen-induced gene transcription that related to occupancy of ERα and RNA PolII on endogenous promoters. In addition, bortezomib inhibited estrogen-dependent growth in soft agar. These results reveal a novel link between proteasome activity and expression of ERα in breast cancer and uncover distinct roles of the chymotrypsin-like activity of the proteasome in the regulation of the ERα pathway.
DOI: 10.1097/00000658-200303000-00013
发表时间: 2003-03-01
期刊: ANNALS OF SURGERY
影响因子: 9
作者:
Bossola, M;Muscaritoli, M;Baccino, FM
通讯作者: Baccino, FM
DOI: 10.1210/me.13.9.1522
发表时间: 1999-09-01
影响因子: --
作者:
Alarid, ET;Bakopoulos, N;Solodin, N
通讯作者: Solodin, N
DOI: 10.1158/0008-5472.can-05-2321
发表时间: 2006-04-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Bazzaro, M;Lee, MK;Roden, RBS
通讯作者: Roden, RBS
DOI: 10.1200/jco.2006.08.8617
发表时间: 2007-02-10
影响因子: 45.3
作者:
Coates, Alan S.;Keshaviah, Aparna;Goldhirsch, Aron
通讯作者: Goldhirsch, Aron
DOI: 10.1210/me.2005-0288
发表时间: 2006-02-01
影响因子: --
作者:
Fowler, AM;Solodin, NM;Alarid, ET
通讯作者: Alarid, ET